ADCBiologicstalePrECOG, LLC.Phase 2
Phase I: Glembatumumab Vedotin (Phase I: Glembatumumab Vedotin)
Squamous Cell Carcinoma of the Lung · Squamous Cell Carcinoma of the Lung
#SquamousCellCarcinomaoftheLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 9.4%임상시험 1상태 DISCONTINUED